Stem cell therapy for female stress urinary incontinence: protocol development, results and lessons learned from a pilot clinical study

This repository contains de-identified data supporting the pilot clinical study that developed and validated standardized protocols for isolation, characterization, and quality control (QC) of autologous skeletal muscle–derived mesenchymal stem cells (SkM‑MSCs) and bone marrow–derived mesenchymal stem cells (BM‑MSCs) under GMP, and assessed the feasibility, safety, and preliminary efficacy of periurethral injections in women with stress urinary incontinence (SUI).